Australia vs Kazakhstan: Access to anti-retroviral drugs, male
Australia
88.0%
in 2023
Kazakhstan
88.0%
in 2024
Australia rank
23rd
Kazakhstan rank
23rd
Access to anti-retroviral drugs, male over time
- Australia
- Kazakhstan
How they compare
Australia currently reports 88.0% against 88.0% in Kazakhstan, a difference of 0.0%.
Across all 24 years both countries report, Australia has been ahead every year.
Australia ranks 23rd and Kazakhstan ranks 23rd of 141 countries.
Australia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Australia | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 54.1% | 2.1% | 52.0% | Australia |
| 2010s | 76.6% | 27.7% | 48.9% | Australia |
| 2020s | 86.5% | 73.0% | 13.5% | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Australia or Kazakhstan?
- Australia, at 88.0% against 88.0% in Kazakhstan as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Australia and Kazakhstan?
- 0.0%, with Australia ahead.
- How many years of comparable data are there for Australia and Kazakhstan?
- 24 years are reported by both, from 2000 to 2023.
- How do Australia and Kazakhstan rank globally for access to anti-retroviral drugs, male?
- Australia ranks 23rd and Kazakhstan ranks 23rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.